X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9594) 9594
Publication (441) 441
Book Review (42) 42
Book Chapter (11) 11
Magazine Article (11) 11
Dissertation (8) 8
Newsletter (7) 7
Conference Proceeding (6) 6
Book / eBook (3) 3
Newspaper Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7823) 7823
male (5406) 5406
antineoplastic combined chemotherapy protocols - therapeutic use (4536) 4536
female (4282) 4282
bleomycin - administration & dosage (4215) 4215
adult (3795) 3795
middle aged (3467) 3467
bleomycin (3037) 3037
bleomycin - therapeutic use (2932) 2932
index medicus (2344) 2344
aged (2324) 2324
oncology (2310) 2310
animals (1972) 1972
cisplatin - administration & dosage (1962) 1962
doxorubicin - administration & dosage (1730) 1730
combined modality therapy (1703) 1703
chemotherapy (1644) 1644
adolescent (1623) 1623
vincristine - administration & dosage (1586) 1586
bleomycin - adverse effects (1431) 1431
mice (1307) 1307
treatment outcome (1285) 1285
cyclophosphamide - administration & dosage (1267) 1267
etoposide - administration & dosage (1244) 1244
vinblastine - administration & dosage (1179) 1179
antineoplastic combined chemotherapy protocols - adverse effects (1145) 1145
cancer (1096) 1096
hodgkin disease - drug therapy (1096) 1096
prognosis (1069) 1069
neoplasm staging (1025) 1025
prednisone - administration & dosage (1021) 1021
carcinoma, squamous cell - drug therapy (944) 944
testicular neoplasms - drug therapy (878) 878
follow-up studies (860) 860
methotrexate - administration & dosage (848) 848
doxorubicin - therapeutic use (769) 769
antineoplastic combined chemotherapy protocols - administration & dosage (762) 762
pulmonary fibrosis (738) 738
cisplatin (732) 732
pulmonary fibrosis - chemically induced (716) 716
remission induction (709) 709
fibrosis (693) 693
antineoplastic agents - therapeutic use (666) 666
survival rate (659) 659
child (655) 655
retrospective studies (655) 655
dacarbazine - administration & dosage (650) 650
vincristine - therapeutic use (642) 642
cisplatin - therapeutic use (610) 610
disease (575) 575
respiratory system (573) 573
hematology (570) 570
procarbazine - administration & dosage (569) 569
time factors (567) 567
therapy (564) 564
vinblastine (564) 564
drug therapy, combination (548) 548
vinblastine - therapeutic use (545) 545
drug administration schedule (542) 542
cyclophosphamide - therapeutic use (516) 516
radiotherapy (514) 514
survival analysis (503) 503
disease-free survival (499) 499
disease models, animal (494) 494
rats (479) 479
hodgkin disease - pathology (474) 474
lung - pathology (467) 467
lymphoma, non-hodgkin - drug therapy (466) 466
mice, inbred c57bl (464) 464
surgery (464) 464
care and treatment (456) 456
antibiotics, antineoplastic - therapeutic use (451) 451
pharmacology & pharmacy (444) 444
neoplasms, germ cell and embryonal - drug therapy (443) 443
pulmonary fibrosis - pathology (442) 442
etoposide (440) 440
prospective studies (440) 440
tumors (430) 430
inflammation (429) 429
hodgkin disease - radiotherapy (419) 419
aged, 80 and over (418) 418
testicular neoplasms - pathology (416) 416
doxorubicin - adverse effects (415) 415
cisplatin - adverse effects (414) 414
head and neck neoplasms - drug therapy (414) 414
combination chemotherapy (413) 413
bleomycin - pharmacology (411) 411
expression (407) 407
young adult (406) 406
prednisone - therapeutic use (394) 394
bleomycin - toxicity (392) 392
lung diseases (390) 390
methotrexate - therapeutic use (389) 389
collagen (385) 385
clinical trials as topic (383) 383
dose-response relationship, drug (382) 382
lung - drug effects (375) 375
child, preschool (370) 370
pulmonary fibrosis - drug therapy (367) 367
fibroblasts (364) 364
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8282) 8282
Japanese (724) 724
German (304) 304
French (226) 226
Chinese (182) 182
Russian (88) 88
Spanish (73) 73
Polish (57) 57
Italian (47) 47
Hungarian (19) 19
Dutch (13) 13
Czech (10) 10
Hebrew (9) 9
Portuguese (9) 9
Bulgarian (4) 4
Croatian (3) 3
Danish (3) 3
Finnish (3) 3
Norwegian (3) 3
Romanian (3) 3
Swedish (3) 3
Korean (2) 2
Serbian (2) 2
Turkish (2) 2
Afrikaans (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 04/2018, Volume 2018, Issue 4, p. CD006545
Background Infantile haemangiomas (previously known as strawberry birthmarks) are soft, raised swellings of the skin that occur in 3% to 10% of infants. These... 
Vascular birthmarks e.g infantile haemangiomas | Adrenal Cortex Hormones | Methylprednisolone | Photochemotherapy | topical steroids | lasers | Bleomycin | corticosteroids | Child health | systemic steroids | Propranolol | Hemangioma, Capillary | Prednisolone | Timolol | W. BIRTH MARKS AND DEVELOPMENTAL ABNORMALITIES OF THE SKIN | vincristine | Antineoplastic Agents | Radiotherapy | interferon | Remission Induction | Skin disorders | laser therapy | Randomized Controlled Trials as Topic | intralesional steroids | Skin Neoplasms | imiquimod | Adrenergic beta‐Antagonists | Lasers, Dye | Birthmarks | Skin | Medicine General & Introductory Medical Sciences | W6 Vascular malformations e.g. port‐wine stains | surgery | Antineoplastic Agents [therapeutic use] | Humans | Prednisolone [adverse effects; therapeutic use] | Child, Preschool | Infant | RANDOMIZED CONTROLLED-TRIAL | INTRALESIONAL BLEOMYCIN | MEDICINE, GENERAL & INTERNAL | PULSED DYE-LASER | Radiotherapy [methods] | TOPICAL PROPRANOLOL | Bleomycin [therapeutic use] | INTENSITY FOCUSED ULTRASOUND | TIMOLOL MALEATE 0.5-PERCENT | UNTREATED HEMANGIOMAS | SEQUENTIAL COMBINATION | RISK-FACTORS | Lasers, Dye [therapeutic use] | Remission Induction [methods] | Skin Neoplasms [therapy] | Adrenal Cortex Hormones [adverse effects; therapeutic use] | ORAL PROPRANOLOL | Hemangioma, Capillary [therapy] | Methylprednisolone [adverse effects; therapeutic use] | Photochemotherapy [methods] | Prednisolone - adverse effects | Methylprednisolone - therapeutic use | Skin Neoplasms - therapy | Hemangioma, Capillary - therapy | Photochemotherapy - methods | Timolol - administration & dosage | Methylprednisolone - adverse effects | Antineoplastic Agents - therapeutic use | Lasers, Dye - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Adrenal Cortex Hormones - adverse effects | Bleomycin - therapeutic use | Propranolol - administration & dosage | Radiotherapy - methods | Remission Induction - methods | Prednisolone - therapeutic use | Adrenergic beta-Antagonists - administration & dosage
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 3, pp. 203 - 212
BEACOPP combination chemotherapy was compared with ABVD chemotherapy in advanced Hodgkin's disease. BEACOPP therapy was associated with higher initial rates of... 
CELL TRANSPLANT | MEDICINE, GENERAL & INTERNAL | VINORELBINE | MOPP | DISEASE | REGIMEN | IFOSFAMIDE | CHEMOTHERAPY | STANDARD | HYBRID | FERTILITY | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Lymphomas | Hodgkin's disease
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 08/2016, Volume 34, Issue 23, pp. 2690 - +
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 2014, Volume 25, Issue 8, pp. 1622 - 1628
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2011, Volume 152, Issue 5, pp. 551 - 560
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 10/2014, Volume 190, Issue 8, pp. 867 - 878
Journal Article
Lancet, The, ISSN 0140-6736, 05/2012, Volume 379, Issue 9828, pp. 1791 - 1799
Summary Background The intensity of chemotherapy and need for additional radiotherapy in patients with advanced stage Hodgkin's lymphoma has been unclear. We... 
Internal Medicine | Radiotherapy Dosage | Doxorubicin/adverse effects | Etoposide/adverse effects | Procarbazine/adverse effects | Prospective Studies | Hodgkin Disease/drug therapy | Humans | Middle Aged | Proportional Hazards Models | Male | Treatment Outcome | Positron-Emission Tomography | Antineoplastic Combined Chemotherapy Protocols/adverse effects | Prednisone/adverse effects | Treatment Failure | Adolescent | Survival Analysis | Adult | Female | Cyclophosphamide/adverse effects | Vincristine/adverse effects | Neoplasm Staging | Bleomycin/adverse effects | SURVIVAL | ABVD | MEDICINE, GENERAL & INTERNAL | COMBINATIONS | POSITRON-EMISSION-TOMOGRAPHY | DISEASE | PROGNOSTIC SCORE | RISK | STANFORD-V | PROGRESSION | MOPP/ABV HYBRID | Doxorubicin - therapeutic use | Hodgkin Disease - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Hodgkin Disease - drug therapy | Etoposide - adverse effects | Prednisone - adverse effects | Etoposide - therapeutic use | Bleomycin - adverse effects | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Chemotherapy | Usage | Care and treatment | PET imaging | Diagnosis | Hodgkin's disease | Cancer | Medical imaging | Meetings | Patient safety | Oncology | Lymphomas | Histology | Radiation therapy | Ovarian cancer
Journal Article